Announcements Trials
Browse Landscape

Phase

Phase 1/2 1Phase 1 1

Status

Recruiting 1Not yet recruiting 1

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other solid neoplasm 2

Conditions

Carcinoma, Non-Small-Cell Lung 261Neoplasms 143Breast Neoplasms 140Colorectal Neoplasms 124Prostatic Neoplasms 94Neoplasm Metastasis 93Multiple Myeloma 92Ovarian Neoplasms 91Lung Neoplasms 86Squamous Cell Carcinoma of Head and Neck 62Pancreatic Neoplasms 62Recurrence 59Endometrial Neoplasms 55Melanoma 52Small Cell Lung Carcinoma 51Leukemia, Lymphocytic, Chronic, B-Cell 48Stomach Neoplasms 47Carcinoma, Renal Cell 46Leukemia, Myeloid, Acute 44Lymphoma, Non-Hodgkin 40Advanced Solid Tumors 39Urinary Bladder Neoplasms 37Triple Negative Breast Neoplasms 36Parkinson Disease 4, Autosomal Dominant Lewy Body 36Lymphoma, Large B-Cell, Diffuse 36Head and Neck Neoplasms 36Carcinoma, Hepatocellular 35Lymphoma, Follicular 30Esophageal Neoplasms 30Myasthenia Gravis 27

Interventions

pembrolizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
INDUSTRY × Locally Advanced or Metastatic Solid Tumors × 30 days × Clear all
NCT07469774 2026-05-28

BC3195 in Combination With Pembrolizumab in Participants With Locally Advanced or Metastatic Solid Tumors

Biocity Biopharmaceutics Co., Ltd.

Phase 1/2 Recruiting
111 enrolled
Other solid neoplasm

Locally Advanced or Metastatic Solid Tumors

NCT07607054 2026-05-26

A First-in-human Phase I Study to Evaluate EMB-15 in Patients With Locally Advanced or Metastatic Solid Tumors.

Shanghai EpimAb Biotherapeutics Co., Ltd.

Phase 1 Not yet recruiting
50 enrolled
Other solid neoplasm

Locally Advanced or Metastatic Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡